| Names | |
|---|---|
| IUPAC name 2-Aminohexanedioic acid | |
| Other names 2-Aminoadipic acid | |
| Identifiers | |
| |
3D model (JSmol) | |
| 1724349 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.008.009 |
| EC Number |
|
| MeSH | 2-Aminoadipic+Acid |
| UNII | |
| |
| |
| Properties | |
| C6H11NO4 | |
| Molar mass | 161.156 g/mol |
| Appearance | Crystalline |
| Density | 1.333 g/mL |
| Melting point | 196 °C (385 °F; 469 K) |
| Boiling point | 364 °C (687 °F; 637 K) |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards | Irritant |
| GHS labelling:[1] | |
| Warning | |
| H317 | |
| P261,P272,P280,P302+P352,P321,P333+P317,P362+P364,P501 | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
α-Aminoadipic acid is one of themetabolic precursor in the biosynthesis oflysine throughα-aminoadipate pathway. Itsconjugate base isα-aminoadipate, which is the prevalent form atphysiological pH.
α-Aminoadipic acid has astereogenic center and can appear in twoenantiomers,L-α-aminoadipate andD-α-aminoadipate. TheL-enantiomer appears during lysine biosynthesis and degradation, whereas theD-enantiomer is a part of certainantibiotics.
Throughsaccharopine and allysine, lysine is converted to α-aminoadipate, which is then degraded all the way toacetoacetate.[2] Allysine is oxidized byaminoadipate-semialdehyde dehydrogenase:[2]
α-Aminoadipate is then transaminated with α-ketoglutaric acid to give 2-oxooadipic acid and L-glutamic acid, respectively, by the action of2-aminoadipate transaminase:[2][3]
α-Aminoadipate appears during biosynthesis of lysine in severalyeast species,fungi, and certainprotists.[4][5][6][7] During this pathway,which is named after α-aminoadipate, the same steps are repeated in the opposite order as in the degradation reactions, namely, α-ketoadipate is transaminated to α-aminoadipate, which is then reduced to allysine, allysine couples with glutamate to give saccharopine, which is then cleaved to give lysine.[4]
A 2013 study identifieds α-aminoadipate as a novel predictor of the development ofdiabetes and suggested that it is a potential modulator ofglucose homeostasis in humans.[8]
D-α-Aminoadipic acid is a part of the antibioticcephalosporin C.[9]